Literature DB >> 20008274

Gene expression profiling of dilated cardiomyopathy in older male EP4 knockout mice.

Pamela Harding1, Xiao-Ping Yang, James Yang, Ed Shesely, Quan He, Margot C LaPointe.   

Abstract

Using a line of mice with cardiac-specific knockout (KO) of the EP4 receptor gene, experiments were designed to determine whether a cardiac phenotype developed with age. Cardiac function was assessed by echocardiography in 23- to 33-wk-old male and female KO and littermate controls (WT) mice. After echocardiography, hearts were removed to assess weight, and then some were further processed for histology [myocyte cross-sectional area (MCSA), interstitial collagen fraction (ICF), and macrophage infiltration] and some for extraction of total RNA and protein. Older male KO mice had reduced ejection fraction (EF) coupled with left ventricular dilatation. MCSA and infiltrating macrophages were not different between groups, but ICF increased by 39% in KO mice. In contrast to male KO mice, 30- to 32-wk-old female KO mice had only a slight reduction in EF. To understand gene expression differences between male WT and KO mice, we performed whole genome gene expression profiling (Illumina BeadChips) on hearts of 30-to 32-wk-old mice. Data indicated that 156 genes were overexpressed in the KO hearts more than twofold, including genes involved in remodeling, inflammation, and oxidative stress. Overexpressed chemokines/cytokines were further examined in hearts of 10- to 12-wk-old male KO mice, and we found that growth differentiation factor-15 (GDF-15) expression was higher in KO than in WT hearts. In conclusion, EP4 knockdown in cardiac myocytes in aged male KO mice is in part associated with increased fibrosis, reduced EF, and dilated cardiomyopathy. Early overexpression of GDF-15 in hearts of male KO mice may contribute to or be a marker of the disease phenotype. The absence of serious cardiac dysfunction in aged female mice suggests a sexual dimorphism in the phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008274      PMCID: PMC2822585          DOI: 10.1152/ajpheart.00746.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  42 in total

1.  The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury.

Authors:  Tibor Kempf; Matthias Eden; Jens Strelau; Marian Naguib; Christian Willenbockel; Jörn Tongers; Jörg Heineke; Daniel Kotlarz; Jian Xu; Jeffery D Molkentin; Hans W Niessen; Helmut Drexler; Kai C Wollert
Journal:  Circ Res       Date:  2006-01-05       Impact factor: 17.367

2.  GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation.

Authors:  Jian Xu; Thomas R Kimball; John N Lorenz; David A Brown; Asne R Bauskin; Raisa Klevitsky; Timothy E Hewett; Samuel N Breit; Jeffery D Molkentin
Journal:  Circ Res       Date:  2006-01-05       Impact factor: 17.367

Review 3.  Structure and function of matrix metalloproteinases and TIMPs.

Authors:  Hideaki Nagase; Robert Visse; Gillian Murphy
Journal:  Cardiovasc Res       Date:  2006-01-05       Impact factor: 10.787

4.  Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.

Authors:  Shin-ichiro Matsumura; Shiro Iwanaga; Satsuki Mochizuki; Hiroyuki Okamoto; Satoshi Ogawa; Yasunori Okada
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

5.  Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies.

Authors:  Andreas S Barth; Ruprecht Kuner; Andreas Buness; Markus Ruschhaupt; Sylvia Merk; Ludwig Zwermann; Stefan Kääb; Eckart Kreuzer; Gerhard Steinbeck; Ulrich Mansmann; Annemarie Poustka; Michael Nabauer; Holger Sültmann
Journal:  J Am Coll Cardiol       Date:  2006-09-27       Impact factor: 24.094

Review 6.  Clinical and genetic issues in familial dilated cardiomyopathy.

Authors:  Emily L Burkett; Ray E Hershberger
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

7.  Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase.

Authors:  Antje Buerger; Olga Rozhitskaya; Megan C Sherwood; Adam L Dorfman; Egbert Bisping; E Dale Abel; William T Pu; Seigo Izumo; Patrick Y Jay
Journal:  J Card Fail       Date:  2006-06       Impact factor: 5.712

8.  SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.

Authors:  Heather M McClung; Stacey L Thomas; Pamela Osenkowski; Marta Toth; Priya Menon; Avraham Raz; Rafael Fridman; Sandra A Rempel
Journal:  Neurosci Lett       Date:  2007-04-21       Impact factor: 3.046

9.  High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory lyme arthritis.

Authors:  Junghee J Shin; Lisa J Glickstein; Allen C Steere
Journal:  Arthritis Rheum       Date:  2007-04

10.  Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen.

Authors:  Minoru Satoh; Christian M Matter; Hisakazu Ogita; Kyosuke Takeshita; Chao-Yung Wang; Gerald W Dorn; James K Liao
Journal:  Circulation       Date:  2007-06-11       Impact factor: 29.690

View more
  19 in total

1.  Loss of secreted frizzled-related protein-1 leads to deterioration of cardiac function in mice and plays a role in human cardiomyopathy.

Authors:  Piotr Sklepkiewicz; Takayuki Shiomi; Rajbir Kaur; Jie Sun; Susan Kwon; Becky Mercer; Peter Bodine; Ralph Theo Schermuly; Isaac George; P Christian Schulze; Jeanine M D'Armiento
Journal:  Circ Heart Fail       Date:  2015-02-10       Impact factor: 8.790

2.  Prostaglandin E2 and an EP4 receptor agonist inhibit LPS-Induced monocyte chemotactic protein 5 production and secretion in mouse cardiac fibroblasts via Akt and NF-κB signaling.

Authors:  Timothy D Bryson; Jacob Ross; Edward Peterson; Pamela Harding
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-06-20       Impact factor: 3.072

3.  PGE2 reduces MMP-14 and increases plasminogen activator inhibitor-1 in cardiac fibroblasts.

Authors:  Kamal M Kassem; Margarette H Clevenger; David L Szandzik; Edward Peterson; Pamela Harding
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-09-26       Impact factor: 3.072

4.  Prostaglandin E2 increases cardiac fibroblast proliferation and increases cyclin D expression via EP1 receptor.

Authors:  Pamela Harding; Margot C LaPointe
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-02-20       Impact factor: 4.006

5.  Development of dilated cardiomyopathy in Bmal1-deficient mice.

Authors:  Mellani Lefta; Kenneth S Campbell; Han-Zhong Feng; Jian-Ping Jin; Karyn A Esser
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-15       Impact factor: 4.733

6.  Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction.

Authors:  Timothy D Bryson; Xiaosong Gu; Remonda M Khalil; Safa Khan; Liping Zhu; Jiang Xu; Edward Peterson; Xiao-Ping Yang; Pamela Harding
Journal:  J Mol Cell Cardiol       Date:  2018-03-06       Impact factor: 5.000

7.  Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion.

Authors:  Pamela Harding; Xiao-Ping Yang; Quan He; Margot C Lapointe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-30       Impact factor: 4.733

Review 8.  The contribution of prostaglandins versus prostacyclin in ventricular remodeling during heart failure.

Authors:  Pamela Harding; David B Murray
Journal:  Life Sci       Date:  2011-08-10       Impact factor: 5.037

9.  Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors.

Authors:  Kai Schledzewski; Cyrill Géraud; Bernd Arnold; Shijun Wang; Hermann-Josef Gröne; Tibor Kempf; Kai C Wollert; Beate K Straub; Peter Schirmacher; Alexandra Demory; Hiltrud Schönhaber; Alexei Gratchev; Lisa Dietz; Hermann-Josef Thierse; Julia Kzhyshkowska; Sergij Goerdt
Journal:  J Clin Invest       Date:  2011-02       Impact factor: 14.808

10.  Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.

Authors:  Xiaosong Gu; Jiang Xu; Liping Zhu; Timothy Bryson; Xiao-Ping Yang; Edward Peterson; Pamela Harding
Journal:  Circ Heart Fail       Date:  2016-08       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.